- Home
- FSHP vs ANIX Comparison
FSHP vs ANIX Comparison
Compare FSHP & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSHP
- ANIX
- Stock Information
- Founded
- FSHP 2018
- ANIX 1982
- Country
- FSHP United States
- ANIX United States
- Employees
- FSHP N/A
- ANIX N/A
- Industry
- FSHP
- ANIX Biotechnology: Pharmaceutical Preparations
- Sector
- FSHP
- ANIX Health Care
- Exchange
- FSHP NYSE
- ANIX Nasdaq
- Market Cap
- FSHP 92.2M
- ANIX 84.7M
- IPO Year
- FSHP 2024
- ANIX 1987
- Fundamental
- Price
- FSHP $10.48
- ANIX $2.65
- Analyst Decision
- FSHP
- ANIX Strong Buy
- Analyst Count
- FSHP 0
- ANIX 3
- Target Price
- FSHP N/A
- ANIX $9.00
- AVG Volume (30 Days)
- FSHP 4.3K
- ANIX 38.7K
- Earning Date
- FSHP 01-01-0001
- ANIX 06-03-2025
- Dividend Yield
- FSHP N/A
- ANIX N/A
- EPS Growth
- FSHP N/A
- ANIX N/A
- EPS
- FSHP 0.20
- ANIX N/A
- Revenue
- FSHP N/A
- ANIX N/A
- Revenue This Year
- FSHP N/A
- ANIX N/A
- Revenue Next Year
- FSHP N/A
- ANIX N/A
- P/E Ratio
- FSHP $52.52
- ANIX N/A
- Revenue Growth
- FSHP N/A
- ANIX N/A
- 52 Week Low
- FSHP $9.99
- ANIX $2.07
- 52 Week High
- FSHP $10.48
- ANIX $4.20
- Technical
- Relative Strength Index (RSI)
- FSHP N/A
- ANIX 47.26
- Support Level
- FSHP N/A
- ANIX $2.53
- Resistance Level
- FSHP N/A
- ANIX $2.79
- Average True Range (ATR)
- FSHP 0.00
- ANIX 0.15
- MACD
- FSHP 0.00
- ANIX -0.01
- Stochastic Oscillator
- FSHP 0.00
- ANIX 35.71
About FSHP FLAG SHIP ACQUISITION CORPORATION
Flag Ship Acquisition Corp is a blank check company formed to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses.
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.